当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2014年第7期 > 正文
编号:12971440
依普利酮与坎地沙坦酯治疗老年性高血压的临床疗效比较(3)
http://www.100md.com 2014年7月1日 孙在茂
第1页

    参见附件。

     [4] McLoughlin P,Ward JP.Hypoxic pulmonary hypertension:the load on the right ventricle[J].Exp Physiol,2013,98(8):1244-1246.

    [5] Robinson K,Kruger P,Prins J, et al. The metabolic syndrome in critically ill patients[J].Best Pract Res Clin Endocrinol Metab,2011,25(2):843-845.

    [6] 刘薇,刘志远,潘灵敏,等.坎地沙坦酯对老年人原发性高血压患者尿微量蛋白排泄的影响[J].疑难病杂志,2012,11(3):214-215.

    [7] Baltaci D, Erbilen E, Turker Y, et al. Predictors of hypertension control in Turkey: the MELEN study[J].Eur Rev Med Pharmacol Sci,2013,17(14):1884-1888.

    [8] Sartelli M,Catena F,Ansaloni L,et al. Complicated intra-abdominal infection in Europe:preliminary data from the first three months of the CLAO study[J].World J Emerg Surg,2012,7(1):15.

    [9] Kansagara D,Fu R,Freeman M, et al. Intensive Insulin therapy in hospitalized patiedts:a systematic review[J].Ann Intern Med,2011,154(4):268-282.

    [10] Kneuertz PJ,Pitt HA,Bilimoria KY, et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery[J].J Gastrointes Surg,2012,16(9):1733-1735.

您现在查看是摘要介绍页,详见PDF附件